Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia. 1984

E H Flewellen, and T E Nelson

UI MeSH Term Description Entries
D008305 Malignant Hyperthermia Rapid and excessive rise of temperature accompanied by muscular rigidity following general anesthesia. Hyperpyrexia, Malignant,Hyperthermia, Malignant,Malignant Hyperpyrexia,Anesthesia Related Hyperthermia,Hyperthermia of Anesthesia,Anesthesia Hyperthermia,Hyperthermia, Anesthesia Related,Malignant Hyperpyrexias
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003620 Dantrolene Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants. Dantrium,Dantrolene Sodium,Sodium, Dantrolene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E H Flewellen, and T E Nelson
September 1982, Anesthesiology,
E H Flewellen, and T E Nelson
May 1982, Der Anaesthesist,
E H Flewellen, and T E Nelson
November 1980, Critical care medicine,
E H Flewellen, and T E Nelson
February 2019, Korean journal of anesthesiology,
E H Flewellen, and T E Nelson
November 1979, FDA drug bulletin,
E H Flewellen, and T E Nelson
July 1980, The Medical letter on drugs and therapeutics,
E H Flewellen, and T E Nelson
May 1981, Journal of the American Veterinary Medical Association,
E H Flewellen, and T E Nelson
June 1976, Anesthesiology,
E H Flewellen, and T E Nelson
October 1994, Tropical doctor,
Copied contents to your clipboard!